Hamouda, Diaa
Jillella, Dinesh V. http://orcid.org/0000-0002-5399-0170
Bhatt, Nirav
Koneru, Sitara
Frankel, Michael R.
Nogueira, Raul G.
Article History
Received: 2 February 2021
Revised: 9 April 2021
Accepted: 12 April 2021
First Online: 29 April 2021
Declarations
:
: RGN reports consulting fees for advisory roles with Stryker neurovascular, cerenovus, medtronic, phenox, anaconda, genentech, biogen, prolong pharmaceuticals, imperative care and stock options for advisory roles with brainomix, Viz-AI, corindus vascular robotics, Vesalio, ceretrieve, astrocyte and cerebrotech. DCH is a consultant for Stryker and Vesalio and holds stock options at Viz.AI. The other authors have no conflict of interest.
Free to read: This content has been made available to all.